Human Embryonic Stem Cell‐Derived Oligodendrocyte Progenitor Cells: Preclinical Efficacy and Safety in Cervical Spinal Cord Injury

Cervical spinal cord injury (SCI) remains an important research focus for regenerative medicine given the potential for severe functional deficits and the current lack of treatment options to augment neurological recovery. We recently reported the preclinical safety data of a human embryonic cell‐derived oligodendrocyte progenitor cell (OPC) therapy that supported initiation of a phase I clinical trial for patients with sensorimotor complete thoracic SCI. To support the clinical use of this OPC therapy for cervical injuries, we conducted preclinical efficacy and safety testing of the OPCs in a nude rat model of cervical SCI. Using the automated TreadScan system to track motor behavioral recovery, we found that OPCs significantly improved locomotor performance when administered directly into the cervical spinal cord 1 week after injury, and that this functional improvement was associated with reduced parenchymal cavitation and increased sparing of myelinated axons within the injury site. Based on large scale biodistribution and toxicology studies, we show that OPC migration is limited to the spinal cord and brainstem and did not cause any adverse clinical observations, toxicities, allodynia, or tumors. In combination with previously published efficacy and safety data, the results presented here supported initiation of a phase I/IIa clinical trial in the U.S. for patients with sensorimotor complete cervical SCI. Stem Cells Translational Medicine 2017;6:1917–1929

[1]  Thomas Vierbuchen,et al.  Generation of oligodendroglial cells by direct lineage conversion , 2013, Nature Biotechnology.

[2]  M. Norenberg,et al.  The pathology of human spinal cord injury: defining the problems. , 2004, Journal of neurotrauma.

[3]  J. Mallet,et al.  Grafted Human Embryonic Progenitors Expressing Neurogenin-2 Stimulate Axonal Sprouting and Improve Motor Recovery after Severe Spinal Cord Injury , 2010, PloS one.

[4]  Colin M. E. Fry,et al.  Biphasic bisperoxovanadium administration and Schwann cell transplantation for repair after cervical contusive spinal cord injury , 2015, Experimental Neurology.

[5]  Jeremy S. Biane,et al.  Spinal cord reconstitution with homologous neural grafts enables robust corticospinal regeneration , 2016, Nature Medicine.

[6]  D. Basso,et al.  A sensitive and reliable locomotor rating scale for open field testing in rats. , 1995, Journal of neurotrauma.

[7]  K. Hochedlinger,et al.  Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination. , 2013, Cell stem cell.

[8]  C. Schmidt,et al.  Rodent Models and Behavioral Outcomes of Cervical Spinal Cord Injury , 2013, Journal of spine.

[9]  J. Schoenen,et al.  Mesenchymal Stem Cell Graft Improves Recovery after Spinal Cord Injury in Adult Rats through Neurotrophic and Pro-Angiogenic Actions , 2012, PloS one.

[10]  P. Gutin,et al.  Human embryonic stem cell-derived oligodendrocyte progenitors remyelinate the brain and rescue behavioral deficits following radiation. , 2015, Cell stem cell.

[11]  S. Stice,et al.  Human embryonic stem cell-derived mesoderm-like epithelium transitions to mesenchymal progenitor cells. , 2009, Tissue engineering. Part A.

[12]  P. London.  Injury , 1969, Definitions.

[13]  W. Tetzlaff,et al.  A contusive model of unilateral cervical spinal cord injury using the infinite horizon impactor. , 2012, Journal of visualized experiments : JoVE.

[14]  M. Carpenter,et al.  Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation , 2005, Glia.

[15]  Monica Siegenthaler,et al.  Human Embryonic Stem Cell‐Derived Oligodendrocyte Progenitor Cell Transplants Improve Recovery after Cervical Spinal Cord Injury , 2009, Stem cells.

[16]  A. Wan,et al.  Engineering cell matrix interactions in assembled polyelectrolyte fiber hydrogels for mesenchymal stem cell chondrogenesis. , 2014, Biomaterials.

[17]  Alexander Sasha Rabchevsky,et al.  Serial Diffusion Tensor Imaging In Vivo Predicts Long-Term Functional Recovery and Histopathology in Rats following Different Severities of Spinal Cord Injury. , 2016, Journal of neurotrauma.

[18]  A. Vaccaro,et al.  The Use of Cell Transplantation in Spinal Cord Injuries , 2016, The Journal of the American Academy of Orthopaedic Surgeons.

[19]  Oswald Steward,et al.  Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cell Transplants Remyelinate and Restore Locomotion after Spinal Cord Injury , 2005, The Journal of Neuroscience.

[20]  J. Gensel,et al.  Behavioral and histological characterization of unilateral cervical spinal cord contusion injury in rats. , 2006, Journal of neurotrauma.

[21]  J. Simard,et al.  A Direct Comparison of Three Clinically Relevant Treatments in a Rat Model of Cervical Spinal Cord Injury , 2015, Journal of neurotrauma.

[22]  R. Shinjo,et al.  Midkine overcomes neurite outgrowth inhibition of chondroitin sulfate proteoglycan without glial activation and promotes functional recovery after spinal cord injury , 2013, Neuroscience Letters.

[23]  V. Dietz.  The applied neuropathology of human spinal cord injury. , 1999, Spinal cord.

[24]  V. Fossati,et al.  Efficient Generation of Myelinating Oligodendrocytes from Primary Progressive Multiple Sclerosis Patients by Induced Pluripotent Stem Cells , 2014, Stem cell reports.

[25]  E. Hall,et al.  Contemporary Clinical Neurophysiology , 1979 .

[26]  X. Bian,et al.  Glial scar and neuroregeneration: histological, functional, and magnetic resonance imaging analysis in chronic spinal cord injury. , 2010, Journal of neurosurgery. Spine.

[27]  Alexander Sasha Rabchevsky,et al.  Experimental modeling of spinal cord injury: characterization of a force-defined injury device. , 2003, Journal of neurotrauma.

[28]  Faith A. Bazley,et al.  Early Intervention for Spinal Cord Injury with Human Induced Pluripotent Stem Cells Oligodendrocyte Progenitors , 2015, PloS one.

[29]  K. Houkin,et al.  Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome , 2010, Brain Research.

[30]  C. Huselstein,et al.  Mesenchymal stem cells for cartilage engineering. , 2012, Bio-medical materials and engineering.

[31]  Nobuko Uchida,et al.  Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[32]  E. Brunette,et al.  Expansion of human embryonic stem cells in defined serum-free medium devoid of animal-derived products. , 2005, Biotechnology and bioengineering.

[33]  J. Fawcett,et al.  Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials , 2007, Spinal Cord.

[34]  D. McTigue,et al.  Oligodendrocyte Fate after Spinal Cord Injury , 2011, Neurotherapeutics.

[35]  R L Lieber,et al.  Acceptable benefits and risks associated with surgically improving arm function in individuals living with cervical spinal cord injury , 2009, Spinal Cord.

[36]  C. Hulsebosch,et al.  Rodent model of chronic central pain after spinal cord contusion injury and effects of gabapentin. , 2000, Journal of neurotrauma.

[37]  H. Ko,et al.  Gross quantitative measurements of spinal cord segments in human , 2004, Spinal Cord.

[38]  A Curt,et al.  Validation of the weight-drop contusion model in rats: a comparative study of human spinal cord injury. , 2000, Journal of neurotrauma.

[39]  Su-Chun Zhang,et al.  Differentiation of human oligodendrocytes from pluripotent stem cells , 2009, Nature Protocols.

[40]  N. Finnerup,et al.  Pain in spinal cord injury. , 2012, Pain management.

[41]  Norman R. Saunders,et al.  Spatio-Temporal Progression of Grey and White Matter Damage Following Contusion Injury in Rat Spinal Cord , 2010, PloS one.

[42]  Chunhui Xu,et al.  Feeder-free growth of undifferentiated human embryonic stem cells , 2001, Nature Biotechnology.

[43]  M. Fehlings,et al.  Delayed Transplantation of Adult Neural Precursor Cells Promotes Remyelination and Functional Neurological Recovery after Spinal Cord Injury , 2006, The Journal of Neuroscience.

[44]  Yi Wei Zhang,et al.  Oligodendrocyte progenitor cells derived from human embryonic stem cells express neurotrophic factors. , 2006, Stem cells and development.

[45]  Walaa F. Alsanie,et al.  Human embryonic stem cell-derived oligodendrocytes: protocols and perspectives. , 2013, Stem cells and development.

[46]  Keung Nyun Kim,et al.  Clinical Trial of Human Fetal Brain-Derived Neural Stem/Progenitor Cell Transplantation in Patients with Traumatic Cervical Spinal Cord Injury , 2015, Neural plasticity.

[47]  E. Wirth,et al.  Preclinical safety of human embryonic stem cell-derived oligodendrocyte progenitors supporting clinical trials in spinal cord injury. , 2015, Regenerative medicine.

[48]  G. PopovichPhillip,et al.  A Direct Comparison of Three Clinically Relevant Treatments in a Rat Model of Cervical Spinal Cord Injury , 2015 .